Biomarkers in Lysosomal Storage Disorders With Reference to Gaucher Disease

被引：0
|
作者：
Cox, Timothy M. [1 ]
机构：
[1] Univ Cambridge, Dept Med, Cambridge CB2 ONN, England
来源：
CLINICAL THERAPEUTICS | 2009年 / 31卷
关键词：
MARKED ELEVATION; CHEMOKINE;
D O I：
10.1016/S0149-2918(09)00428-7
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：S183 / S184
页数：2
相关论文
共 50 条
  • [1] Biomarkers for lysosomal storage disorders: identification and application as exemplified by chitotriosidase in Gaucher disease
    Aerts, Johannes M.
    van Breemen, Marielle J.
    Bussink, Anton P.
    Ghauharali, Karen
    Sprenger, Richard
    Boot, Rolf G.
    Groener, Johanna E.
    Hollak, Carla E.
    Maas, Mario
    Smit, Suzanne
    Hoefsloot, Huub C.
    Smildel, Age K.
    Vissers, Johannes P. C.
    de Jong, Sheryas
    Speijer, Dave
    de Koster, Chris G.
    [J]. ACTA PAEDIATRICA, 2008, 97 : 7 - 14
  • [2] Glycosphingolipids and lysosomal storage disorders as illustrated by gaucher disease
    Aerts, Johannes M. F. G.
    Kuo, Chi-Lin
    Lelieveld, Lindsey T.
    Boer, Daphne E. C.
    van der Lienden, Martijn J. C.
    Overkleeft, Herman S.
    Artola, Marta
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2019, 53 : 204 - 215
  • [3] PATHOGENESIS OF LYSOSOMAL STORAGE DISORDERS AS ILLUSTRATED BY GAUCHER DISEASE
    AERTS, JMFG
    VANWEELY, S
    BOOT, R
    HOLLAK, CEM
    TAGER, JM
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 1993, 16 (02) : 288 - 291
  • [4] Lysosomal Storage Disorders and Parkinson's Disease: Gaucher Disease and Beyond
    Shachar, Tamar
    Lo Bianco, Christophe
    Recchia, Alessandra
    Wiessner, Christoph
    Raas-Rothschild, Annick
    Futerman, Anthony H.
    [J]. MOVEMENT DISORDERS, 2011, 26 (09) : 1593 - 1604
  • [5] Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases
    Aerts, JMFG
    Hollak, CEM
    van Breemen, M
    Maas, M
    Groener, JEM
    Boot, RG
    [J]. ACTA PAEDIATRICA, 2005, 94 : 43 - 46
  • [6] Therapeutic strategies to ameliorate lysosomal storage disorders - a focus on Gaucher disease
    Sawkar, A. R.
    D'Haeze, W.
    Kelly, J. W.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2006, 63 (10) : 1179 - 1192
  • [7] Therapeutic strategies to ameliorate lysosomal storage disorders – a focus on Gaucher disease
    A. R. Sawkar
    W. D’Haeze
    J. W. Kelly
    [J]. Cellular and Molecular Life Sciences CMLS, 2006, 63 : 1179 - 1192
  • [8] Efficacy of pentosan polysulfate in in vitro models of lysosomal storage disorders: Fabry and Gaucher Disease
    Crivaro, Andrea N.
    Mucci, Juan M.
    Bonder, Constanza M.
    Ormazabal, Maximiliano E.
    Ceci, Romina
    Simonaro, Calogera
    Rozenfeld, Paula A.
    [J]. PLOS ONE, 2019, 14 (05):
  • [9] NEUROLOGICAL MANIFESTATIONS IN PAKISTANI LYSOSOMAL STORAGE DISORDERS PATIENTS AND MOLECULAR CHARACTERIZATION OF GAUCHER DISEASE
    Gul, Rutaba
    Firasat, Sabika
    Hussain, Mulazim
    Tufail, Muhammad
    Ahmad, Waheed
    Afshan, Kiran
    [J]. GENETIKA-BELGRADE, 2021, 53 (03): : 1017 - 1029
  • [10] New Developments in Biomarkers for Lysosomal Storage Disorders
    Aerts, Johannes M.
    [J]. CLINICAL THERAPEUTICS, 2008, 30 : S92 - S93
12345